Not applicableStudy completedNCT00846807
What this trial is testing
Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery
Who this might be right for
Arthroplasty, ReplacementThromboembolism
Boehringer Ingelheim 5,476